Symmetry Investments’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Symmetry Investments’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,600	Closed	-$1.58M	–	259
2024 Q1	$1.58M	Buy	+16,600	New	+$1.54M	0.09%	100
2023 Q4	–	Sell	-16,200	Closed	-$1.18M	–	246
2023 Q3	$1.18M	Buy	+16,200	New	+$1.29M	0.24%	88
2022 Q1	–	Sell	-6,000	Closed	-$672K	–	141
2021 Q4	$672K	Buy	+6,000	New	+$724K	0.21%	73

Other funds holding XBI

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Symmetry Investments's XBI Position: Q2 2024 in Review

Symmetry Investments sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2024, closing a stake of 16,600 shares — an estimated $1.58M sold.

Symmetry Investments first reported a position in XBI in Q4 2021 and held it in 3 quarters. The position peaked at $1.58M in Q1 2024. 761 funds tracked by Wall St. Rank hold XBI as of Q2 2024.

Symmetry Investments reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2024 after selling out during the quarter.
Symmetry Investments sold 16,600 State Street SPDR S&P Biotech ETF shares in Q2 2024, an estimated $1.58M.
Symmetry Investments first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 3 quarters.
Symmetry Investments's State Street SPDR S&P Biotech ETF position peaked at $1.58M in Q1 2024.
761 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2024.

Based on Symmetry Investments's 13F filing for Q2 2024, filed 13 Aug 2024.